People covered by Obamacare and Medicaid may see health care costs rise, but for people on Medicare, Biden-era negotiated ...
Caliway has completed submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for a Phase 2 clinical study of CBL-514 ...
Asian shares are mixed in thin holiday trading, with most markets in the region and elsewhere closed for Christmas ...
While the drugs have become spectacularly popular, their high prices, along with spotty insurance coverage, have left them ...
Caliway has completed submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for a Phase 2 clinical study of CBL-514 for weight management ...
The Chosun Ilbo on MSN
Novo Nordisk's oral Wegovy approval intensifies obesity drug competition
The era of "oral obesity medications" has officially begun as Danish pharmaceutical company Novo Nordisk’s obesity treatment received U.S. Food and Drug Administration (FDA) approval in pill form.
About 14% of adults in Philadelphia have diabetes, one of the highest rates in the country, the city said, and Black and ...
Wall Street closed higher and reached more records Wednesday on a holiday-shortened trading day. The Standard & Poor’s 500 index rose 22.26 points, or 0.3%, to 6,932.05. The Dow Jones industrial ...
Wall Street closed higher and reached more records Wednesday on a holiday-shortened trading day. Trading was extremely light ...
Philadelphia has filed a lawsuit against several major drug manufacturers and pharmacy benefit managers, accusing them of ...
AMGN signs a pricing deal with the Trump administration, cutting U.S. drug costs, expanding DTC access and securing tariff relief tied to domestic investment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results